Home / 510(k) Clearances / K162167

510(k) K162167

Caphosol Artifical Saliva Tablets by Eusa Pharma (Uk) Limited — Product Code LFD

K162167 is an FDA 510(k) premarket notification submitted by Eusa Pharma (Uk) Limited for the device "Caphosol Artifical Saliva Tablets". The FDA issued a decision of Substantially Equivalent on March 31, 2017. The device falls under product code LFD (Saliva, Artificial), a Class U device. Eusa Pharma (Uk) Limited has at least 1 other 510(k) clearance on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
March 31, 2017
Date Received
August 3, 2016
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Saliva, Artificial
Device Class
Class U
Regulation Number
Review Panel
DE
Submission Type

Other clearances by Eusa Pharma (Uk) Limited

  • K234015 — Caphosol® Artifical Saliva (32 doses sachet box) (March 11, 2024)

Other clearances for product code LFD

  • K253778 — Allday Moisturizing Rinse (February 27, 2026)
  • K250390 — CloSYS® Dry Mouth Sensitive Mouth Rinse (May 19, 2025)
  • K240508 — Salivea Dry Mouth Moisturizing Gel (Dry Mouth Moisturizing Gel) (April 19, 2024)
  • K234015 — Caphosol® Artifical Saliva (32 doses sachet box) (March 11, 2024)
  • K231205 — GuruNanda Dry Mouth Oral Rinse and GuruNanda Dry Mouth Oral Spray (August 22, 2023)
  • K202689 — Dentilube Spray (September 3, 2021)
  • K203567 — Oral-B Dry Mouth Oral Rinse (April 5, 2021)
  • K201277 — Oral-B Dry Mouth Oral Rinse (September 2, 2020)
  • K181839 — CVS Health Dry Mouth Spray, OraLabs Dry Mouth Spray (November 21, 2019)
  • K190144 — MucoPEG (November 5, 2019)

FDA data resources